Table 1.
Cellular Pathway | Cellular Function | CD44 ICD Interaction(s) | Ref(s) |
---|---|---|---|
Cell trafficking | HA endocytosis, pericellular matrix retention, and organization |
Absence of ICD | [36] |
CD44–HA endocytosis and degradation | MARCH-VIII ubiquitin ligase |
[37] | |
CD44 endocytic recycling and stabilization, stemness, and EMT | Hook1, EHD1, and EHD2 | [39,40,42] | |
Sustained EGFR signaling and survival | Rab7A | [44] | |
Cytoskeletal organization | Growth, anchorage-independent growth, migration, adhesion, chemotaxis, and leukocyte binding |
ERM, merlin, and ankyrin | [4,30,31,52,53,54,55,56,57,60,69,97] |
Migration and proliferation | IQGAP1 | [40,67,68] | |
Contact inhibition of growth, migration, apoptosis, and proliferation |
Merlin | [85,86,87,89,90,91,93] | |
Contact inhibition of growth | PAR1b | [98] | |
Transcription | Apoptosis, survival, migration, and adhesion |
iASPP | [40,103] |
CD44 expression | CBP/p300 transcriptional activator |
[110] | |
Cell cycle progression | CREB | [117] | |
Stemness and therapeutic resistance |
HIF-2 alpha | [118] | |
Stemness and therapeutic resistance |
Oct4, Sox2, and Nanog | [119,120] | |
Metabolism | Survival, stemness, and therapeutic resistance |
LDH, PFKFB4, ALDOC, and PDK1 | [116,130,132] |
Survival and therapeutic resistance |
PKM2 | [40,121] |